FASN and prediabetes syndrome: Previous animal studies have shown that small-molecule inhibitors targeting fatty acid synthase can improve hepatic function, reduce inflammation, and attenuate oxidative stress in obese mice fed a high-sugar diet (44).Our findings also showed that patients with diabetes or prediabetes and concurrent HUA had significantly higher HOMA-IR values, suggesting more severe insulin resistance in this group.